Nathan Rich
Stock Analyst at Goldman Sachs
(0.99)
# 3,850
Out of 5,006 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $22.31 | -5.87% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $145.36 | +34.84% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $12.52 | +139.62% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $10.55 | -24.17% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $20.63 | -15.17% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $295.20 | +30.42% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $20.66 | -32.24% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $19.96 | -44.89% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $131.50 | +71.10% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $627.78 | +3.54% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $76.84 | +14.52% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $17.11 | -29.87% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $66.04 | +28.71% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $10.13 | +8.59% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $200.57 | +67.02% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $358.77 | +49.12% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $22.31
Upside: -5.87%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $145.36
Upside: +34.84%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $12.52
Upside: +139.62%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $10.55
Upside: -24.17%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $20.63
Upside: -15.17%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $295.20
Upside: +30.42%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $20.66
Upside: -32.24%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $19.96
Upside: -44.89%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $131.50
Upside: +71.10%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $627.78
Upside: +3.54%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $76.84
Upside: +14.52%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $17.11
Upside: -29.87%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $66.04
Upside: +28.71%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $10.13
Upside: +8.59%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $200.57
Upside: +67.02%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $358.77
Upside: +49.12%